ArticleIntegrative cancer therapies

Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study.

Chia-Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.